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múltiples en cirugía 
coronaria: razonamiento  
e importancia
James Tatoulis
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Royal Melbourne Hospital. Australia
El desarrollo progresivo de ateromatosis y el fra-
caso a largo plazo de los injertos venosos ha condu-
cido a la utilización de injertos arteriales en cirugía 
coronaria. La arteria mamaria interna izquierda 
para revascularizar la arteria descendente anterior, 
pero los injertos arteriales múltiples son todavía 
infrecuentes. Las limitaciones son un tiempo opera-
torio prolongado y la posible influencia sobre la 
morbilidad peroperatoria, en especial sobre la in-
fección esternal, así como la capacidad de los injer-
tos arteriales para proporcionar flujo adecuado. 
La evidencia acumulada apoya el uso de injertos 
arteriales múltiples; hay comunicaciones que confir-
man que dos arterias mamarias son mejor que una, 
y que la revascularización arterial completa podría 
ser, incluso, mejor. Estas estrategias arteriales resul-
tarían en una supervivencia a 10 años un 10% supe-
rior, asociándose a una tasa inferior de eventos 
cardíacos. La introducción de la arteria radial y de 
la arteria gastroepiploica ha ampliado la aplicabili-
dad de los injertos arteriales en intervenciones pri-
marias y reintervenciones. La preferencia por los 
injertos arteriales evita las complicaciones de la ex-
tremidad inferior y facilita una deambulación pre-
coz. Su permeabilidad es superior a cualquier 
intervalo postoperatorio y la diferencia y superiori-
dad sobre las venas aumenta con el tiempo.  
Los injertos arteriales en la enfermedad multi-
vaso pueden utilizarse en la cirugía coronaria con 
y sin circulación extracorpórea. La revasculariza-
ción arterial completa también ofrece resultados 
superiores en comparación con los dispositivos en-
docoronarios liberadores de fármacos en el segui-
Multiple arterial grafting in coronary surgery: 
rationale and importance
concern over the progressive development of 
atheroma and long-term failure of saphenous vein 
grafts in coronary surgery has led to the use of 
arterial grafts. Though the left internal thoracic 
artery is widely used to revascularize the left an-
terior descending, multiple arterial grafting re-
mains uncommon. Barriers include prolonging 
operation and anesthetic times, and concerns re-
garding perioperative morbidity, particularly in-
creased sternal infection, and the ability of arte-
rial grafts to provide adequate flow.
However, the accumulated evidence supports 
the use of multiple arterial grafts, with multiple 
reports indicating that two internal thoracic ar-
tery grafts are better than one, and that total 
arterial grafting may be better still. These arte-
rial strategies may result in superior survivals of 
10% or more after 10 years of follow-up, and ad-
ditionally are associated with fewer interval ma-
jor cardiac adverse events. The introduction of 
radial artery, and to a lesser extent gastroepip-
loic artery conduits, has widened the applicabil-
ity of arterial grafting in both routine primary 
surgeries, but also in reoperations. Preference for 
arterial over vein grafts avoids leg wound com-
plications and ensures earlier ambulation. Paten-
cies of arterial grafts are superior at every inter-
val postoperatively, and the difference (and 
superiority) over vein grafts increases progres-
sively with time. 
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miento superior a 3 años, con menor tasa de 
re intervenciones y coste y mejor supervivencia. 
Palabras clave: Injertos arteriales coronarios. 
Revascularización miocárdica. Arteria radial. 
Stents coronarios.
Arterial grafting for multi-vessel coronary dis-
ease can be used for either on-pump or off-pump 
surgery. It also yields superior results compared 
to multi-vessel drug eluting stents for follow-ups 
three years and beyond, with fewer re-interven-
tions, lower costs, and better survival.
Key words: Arterial coronary graft conduits. 
Myocardial revascularization. Radial artery. Co-
ro nary stents.
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INTRODUCTION
The use of arterial conduits is one of the most sig-
nificant advances in coronary artery bypass grafting 
(CABG) since its inception in 1967. Although improved 
myocardial protection and off-pump techniques have 
been additional major advances, these have largely im-
proved the immediate perioperative results. Arterial con-
duits can be used in addition to optimum myocardial 
protection, on- or off-pump strategies, and have a pro-
found influence on the long-term prognosis, with less 
symptom recurrence, fewer myocardial infarctions, hos-
pital admissions, and reoperations, and result in supe-
rior long-term graft patencies and patient survival1-3.
This article will consider the barriers to arterial/cor-
onary revascularization (including total arterial revascu-
larization), and present the rationale for arterial grafting, 
its role in special circumstances, and the opportunities 
to compete with percutaneous coronary intervention and 
coronary stenting.
REQUIREMENTS FOR ARTERIAL 
GRAFTING
Arterial conduits must be harvested atraumatically. 
Spasm due to handling and the cool temperature of the 
operating room should be minimized and reversed4. We 
use topical papaverine 0.5% (papaverine 30 mg in 60 ml 
of the patients’ heparinized arterial blood at 37º C to-
gether with Ringer’s lactate), intravenous nitroglycer-
ine (30-200 μg/min) intraoperatively and for the first 
24 hours, and amlodipine, a once-daily oral calcium 
channel blocker, 5 mg for six months5. In addition to 
papaverine, phenoxybenzamine and glyceryl trinitrate/
verapamil solutions are also effective topically6,7.
Competitive flow must be avoided and will be ad-
dressed later. In general, “string signs” secondary to 
competitive flow will occur if an internal thoracic artery 
(ITA) graft is anastomosed to a coronary artery that has 
a stenosis of < 50%. Radial artery (RA) and right gas-
troepiploic artery (RGEA) grafts have a higher incidence 
of failure if the native coronary stenosis is < 80%8.
Arterial grafting must be achieved with optimum 
contemporary results (perioperative mortality of 1%, and 
an incidence of major morbidities of 1% or less each) 
using the most effective myocardial, cerebral, and renal 
protective strategies available in CABG practice. In a 
recent multicentre 10-year analysis of over 70,000 pa-
tients, Baskett, et al. reported an increase of complete 
arterial grafting from 3 to 12% with no change in peri-
operative mortality (1.5% for left ITA plus vein graft vs. 
1.7% for all arterial; p = 0.56)9.
BARRIERS TO TOTAL ARTERIAL 
GRAFTING 
The left ITA (LITA) for the left anterior descending 
(LAD), and saphenous vein grafts (SVG) for all other 
vessels, remains the universal CABG strategy in over 
90% of cases. Even as recently as 2003, the Society of 
Thoracic Surgeons database showed only 80% of pa-
tients received one arterial graft, and < 4% received two 
arterial grafts. In the UK, < 10% of patients received two 
arterial grafts. This prompts the question, why are mul-
tiple arterial grafts not more frequently used?
Undoubtedly, extra time is required. Whilst the left RA 
can be harvested simultaneously with the left ITA, harvest-
ing of the right ITA, or the right RA (as part of a bilateral 
RA procedure) takes an additional 30-45 minutes.
There is a perception of increased perioperative mortal-
ity and morbidity associated with multiple arterial grafting; 
however, with due care, this has not been the case (Table 
I). Concerns regarding increased rates of sternal wound 
infection can be overcome by using skeletonized ITA and, 
if necessary, avoiding bilateral ITA in grossly obese, insu-
lin-dependent diabetic patients with significant chronic 
obstructive airways disease. Excellent glycemic control is 
also important and can be readily achieved by insulin infu-
sions5,10,11. However bilateral ITA could still be appropriate 
to consider for the majority of patients. 
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The lack of large randomized studies comparing 
single ITA and bilateral ITA are also of a concern, which 
undermines the longer and more complex operation. 
Arterial grafting is also considered to be more techni-
cally demanding, but this is unlikely as all surgeons use 
the left ITA daily in their practice. The right ITA is no 
different (and in most right-handed people often larger), 
and the RA are larger still and more robust. Arterial 
grafts are always of larger caliber than the coronary to 
be grafted, except occasionally for the right coronary 
artery. It is a matter of patience rather than additional 
technical skill12-15.
A further concern is that the flow through arterial 
grafts may be insufficient to meet the myocardial de-
mands. This is unfounded (providing the grafts are not 
in spasm, not damaged). Measured flows into coronary 
territories range from 30-60 ml/minute, whereas free 
flow from an ITA usually exceeds 100 ml/min and is 
even greater for skeletonized ITA and for an RA16,17.
EVIDENCE AND RATIONALE FOR 
(TOTAL) ARTERIAL GRAFTING 
One internal thoracic artery is better 
than none
Since 1986, it has been widely recognized that a left 
ITA to the LAD conferred superior long-term prognosis, 
with fewer subsequent cardiac events, hospital readmis-
sions, reoperations, and better survival, linked to better 
left ITA to LAD patencies as compared to SVG paten-
cies1,2,9,18.
Additionally, using the left ITA in all patients under 
both elective and urgent circumstances, even in the elderly 
(though this lengthened the procedure) was associated with 
improved perioperative mortality in all patients as well. 
Leavitt, et al. found that in a cohort of almost 22,000 pa-
tients, operative mortality was 2.2% when the left ITA was 
used as opposed to 4.9% when only vein graft was used 
(p < 0.001). Left ITA grafts were protective across all 
patient ages, and disease subgroups19. In the large cohort 
(70,000 patients) studied by Baskett, et al., operative mor-
tality was 1.5% when one or more arterial grafts were used 
compared to 6.9% for vein grafts only (p < 0.001)9.
Two internal thoracic artery grafts are 
better than one
Multiple studies from centers in different countries 
and continents have consistently reported, in large groups 
of patients, that two ITA grafts, particularly to the LAD 
and circumflex, were associated with even better long-
term results (Table II)3,10,12,13,15,17,20-24. 
For bilateral ITA, 10-year survival is 87-90%. For 
single ITA, 10-year survival is 78-80%. Put alterna-
tively, a patient with two ITA grafts (especially to the 
left side) has a 28% less chance of dying over 10 years 
compared to when only a single ITA is used (Fig. 1). 
These differences take 10 years or more to become ap-
parent, and become progressively divergent with time 
(10-20 years postoperative). Use of bilateral ITA is also 
associated with a greater freedom from reoperation or 
re-intervention as compared to one ITA. Freedom from 
re-intervention at 10 years is 80% for bilateral ITA and 
60% for single ITA, i.e. a 50% less chance of re-inter-
vention over 10 years (Fig. 2). The magnitude of the 
difference becomes extremely important to patients who 
are less than 70 years old at the time of CABG.
Total arterial grafting maybe better still
Total arterial revascularization with the two ITA, or 
the addition of an RA(s) or RGEA to bilateral ITA, ap-
pears to confer an additional advantage. Thus far 
there are reported trends towards this. Total arterial 
TABLE I. MULTIPLE ARTERIAL GRAFTING – PERIOPERATIVE RESULTS
Group Operative mortality % Stroke % Deep sternal infection %
Cleveland Clinic 0.7 1.1 2.3
Tatoulis/Buxton 0.9 1.2 0.9
Mayo Clinic 0.0 1.2 2.2
Calafiore 1.2 1.2 1.5
Tector 0.9
Stevens 1.2 1.3
Baskett 1.7
Berreklouw 1.0 1.0 0.0
Schmidt 1.8 1.0
Galbut 2.7 1.4 1.4
Dion 2.0 0.5 4.1
Barner 0.0 2.2 0.0
Mohr 3.0 1.6 2.2
Bical 1.6 1.1 1.1
Average 1.3% 1.1% 1.7%
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revascularization can be achieved with the same ex-
cellent perioperative results as for single ITA and bi-
lateral ITA5,9,11,13,17,19,25. In our Melbourne experience, 
perioperative mortality for total arterial revascularization 
was 0.7%5 and unadjusted survival was 92% at 10 years 
compared to 72% for those patients having only a left 
ITA plus vein graft (Fig. 3).
Arterial graft patencies are always better
Saphenous vein graft patencies are generally good in 
the short and intermediate term (90-95% at one month, 
80-85% at 3-5 years). Patencies, however, decline as 
subendothelial and medial fibrotic and proliferative 
changes occur in the 3-5 year timeframe and are then 
followed by atherothrombotic changes, five years and 
beyond18 (Fig. 4). 
Some optimism for better SVG patencies is present 
with the use of improved vein harvesting techniques, 
which include the perivascular tissues so that the vasa-
vasorum are not interrupted, avoidance of distension 
trauma, and aggressive use of statin anticholesterol 
drugs.
However, in all reports, arterial graft patencies are 
always superior to those of SVG at the same timeframes 
and in the same patients. This applies to even contem-
porary experiences. Importantly, patency results diverge 
and significantly advantage arterial grafts with time.
− Left ITA 90-95% patency at 10-20 
years1,2,5,8,12,14,15,17,26,27
− Right ITA 80-90% patency at 10 years
Figure 1. Composite survival graph from referenced studies, comparing 
bilateral internal thoracic artery graft patients (BITA) to single internal 
thoracic artery patients (SITA). Those with BITA have a 28% less chance 
of dying over 10 years.
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Figure 2. Composite graph from the referenced studies showing freedom from 
reoperation for patients having bilateral internal thoracic arteries (BITA) 
versus those with only a single internal thoracic artery (SITA). At 10 years, 
there is a 50% less chance of re-intervention for those having BITA.
TABLE II. RATIONALE/EVIDENCE FOR ARTERIAL GRAFTING: 
TWO INTERNAL THORACIC ARTERY GRAFTS ARE BETTER 
THAN ONE
Lytle, Sabik, et al. Cleveland Clinic
Buxton, Tatoulis Melbourne
Schaff, et al. Mayo Clinic
Tector Milwaukee
Barner St Louis
Calafiore, et al. Chieti/Milan
Dion Brussels
Taggart Oxford, UK
Steven, et al. Montreal
Berreklouw Netherlands
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Figure 3. Unadjusted survival curves from the University of Melbourne 
experience 1986-2002. Comparing patients having total arterial revascu-
larization (TAR) to those patients having a left internal thoracic artery 
(LITA) plus saphenous vein grafts (VG). An unadjusted 20% superior 
survival for total arterial revascularization at 10 years.
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 90-95% patency when used to LAD at 10 
years8,12,14,15,17
− RA 90% at 5 years, 80% at 10 years8,17,25,28-32
− RGEA 90% at 5 years, 60% at 10 years33
− SVG 70-80% at 5 years, 50% at 10 years, 30% 
at 15 years1,8,18,25,26
Figure 5 shows graft patencies that have been amal-
gamated from the referenced publications.
In all angiograms, arterial grafts are smooth and do 
not show atheromatous and thrombotic changes (unlike 
SVG). Abnormalities in arterial grafts, when they occur, 
are confined to localized stenosis, string signs, or com-
plete occlusions (Fig. 6).
Multiple arterial coronary artery bypass 
grafting is better than stents
Although periprocedural mortality and morbidity is 
similar to percutaneous coronary intervention/stents, 
CABG is superior within three years of follow-up, being 
more cost effective, with fewer major adverse cardiac 
events, fewer re-interventions, and better survival34-36.
Advantages in cardiac reoperations
The presence of an in situ functioning arterial graft, 
particularly the left ITA to LAD in a patient having a 
reoperation (for progression of coronary artery disease, 
graft failure, or development of interval aortic stenosis), 
confers a significant benefit in perioperative mortality 
and morbidity. Multiple reports from multiple centers 
with an aggregate of over 3,000 coronary reoperations 
show a benefit in operative mortality when arterial grafts 
are either previously present or used: a mean operative 
morality of 1.9% for arterial grafts versus 5% when 
arterial grafts are not previously present nor used at the 
reoperation (Table III)37.
As arterial grafts do not develop atherothrombotic dis-
ease, there is much less risk of distal coronary atheroem-
bolism (which is often fatal) in the pre-bypass period or 
during subsequent cardiac mobilization (Fig. 7).
Additional and better conduits will be available at the 
reoperation. If the first operation was a left ITA/SVG 
procedure, then presumably the best SVG conduits were 
used. Hence, it would not be logical to use further SVG 
conduits as the original ones would have failed, leading 
to the reoperation, and the residual SVG would be the 
Figure 4. Angiograms, 10 years post-op in the same patient. Left panel 
shows atheromatous disease in a saphenous vein graft to the first cir-
cumflex marginal. Right panel shows a smooth aortocoronary radial 
artery graft to an inferior circumflex marginal. RA: radial artery; OM: 
obtuse marginal; VG: vein graft.
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Figure 5. Composite graph, from the referenced papers, showing patency 
for different coronary conduits up to 15 years post-op. Left internal tho-
racic artery (LITA), right internal thoracic artery (RITA), radial artery 
(RA), right gastroepiploic artery (RGEA), saphenous vein graft (VG).
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Figure 6. The left panel shows the radial artery (RA) graft to be a string 
sign when it was grafted to a large dominant right coronary artery (RCA) 
with only a moderate 50% stenosis. Angiogram three years post-op.
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least desirable. Alternatively, the right ITA (if appropri-
ate) and one or both radial arteries could be available 
providing significant amounts of additional, new, good 
quality conduit38.
The primary use of certain arterial grafts at reoperation 
may simplify the procedure and produce better results. The 
right ITA may be used to the right coronary system, either 
directly or as a composite extended graft using the RA. The 
RGEA may be used to the posterior descending artery33, and 
an RA may be used from the descending thoracic aorta to 
the lateral wall of the heart via left thoracotomy38. All these 
new arterial grafts can be placed in these reoperations us-
ing off-pump techniques, simplifying the reoperation and 
reducing perioperative mortality and morbidity (Fig. 8).
The use of arterial grafts has resulted in fewer reop-
erations. At 10 years post-op, those with a bilateral ITA 
have an approximate chance of a 20% re-intervention 
rate (2% per year), whereas those with a single ITA have 
a 40% chance of a re-intervention at 10 years (4% per 
year)10,21-24. In our own experience, the rate of reopera-
tions has reduced from 7% of our annual case load in 
1990 to 1995, to < 3% of our case load per annum 
in 200538. It is acknowledged that SVG stenting and 
statins may have played a role; nevertheless, it also co-
incides with the application of widespread total arterial 
revascularization from 1995 onwards.
A further advantage is that the 10-year survival fol-
lowing a reoperation is superior (75-85%) when an ITA 
or arterial graft is used at the reoperation by comparison 
to when only vein graft is used (66-71%; p = 0.004)39,40.
Other general advantages
Less infection
As legs and thighs are avoided (by not using SVG) 
the incidence of sternal infection and mediastinitis can 
be reduced.
Better healing
The forearms are well vascularized, muscular, with 
a minimum of subcutaneous adipose tissue, and heal 
well by comparison to thigh wounds or leg wounds, 
particularly in diabetic patients. Although SVG can be 
harvested by endoscopic techniques to reduce wound 
problems, they still have a limited application and the 
hardware is expensive.
Earlier ambulation
The avoidance of leg incisions enables patients, par-
ticularly the elderly, to ambulate and be discharged ear-
lier25,30,38.
Competitive flow for arterial grafts
This is the Achilles heel of arterial grafting, espe-
cially with RA and RGEA. For the ITA, native coronary 
artery stenosis should be at least 50% to avoid string 
signs8,26. However, for the RA and RGEA, the native 
coronary artery stenosis should be at least 80% to ensure 
excellent long-term patency8,28-30,33. When LAD stenosis 
was < 60%, left ITA patency was 92% compared to 97% 
when LAD stenosis was > 60% (p = 0.008). Radial ar-
tery patency was 83% when native coronary artery 
stenosis was < 80% compared to 92% when it was > 
80% (p = 0.04)8.
One should avoid an SVG in the same system with 
a left ITA, without a 90% stenosis isolating the two 
grafts (e.g. left ITA to a 70% LAD, and a vein graft to 
a 70% diagonal). This may result in the larger SVG 
taking over the revascularization of both the diagonal 
and LAD territories with a subsequent string sign in 
the left ITA8.
Similarly, replacing a diseased but functioning SVG 
to the LAD at reoperation with a left ITA should be 
avoided unless: 
− the left ITA is large with a free flow of > 100 
ml/min
− there is a > 80% stenosis in the SVG
TABLE III. OPERATIVE MORTALITY IN REOPERATIONS: 
ARTERIAL GRAFTS USED VS. VEIN GRAFTS
2.1 vs. 4.9% (n = 1,663) Lytle JTCVS. 1994;107:675.
0.0 vs. 4.8% (n = 189) Christenson Cardiovasc Surg. 1995;3: 
163.
2.3 vs. 5.0% (n = 1,331) Tatoulis J Card Surg. 2004;19:296.
0.0 vs. 5.4% (n =  59) Cameron Adv Cardiol. 1988;36:84.
Figure 7. A patent but diseased right coronary artery (RCA) vein graft. 
Intraoperative distal atheroembolism during cardiac mobilization resul-
ted in acute inferior ischemia. Fortunately, this was reversed by retrogra-
de flushing of the coronaries with retrograde cardioplegia and distal 
posterior descending artery coronary grafting.
Danger of athero-embolism
From a diseased but patent
Right Coronary Vein Graft
RCA Vein Graft
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− or the diseased SVG is left in situ in addition to 
the new left ITA37,38,40.
Radial artery, or RGEA to the circumflex, or right co-
ronary artery/posterior descending artery should be avoided 
if the native coronary stenosis is < 80%8,17,25-30,32,33,41.
Approach to a moderately stenosed  
(50-70%) large right coronary artery
There is no evidence that arterial grafts in this setting 
are important or that they will confer any particular 
benefit. Hence, a pragmatic approach is required:
− Large right coronary artery, < 80% stenosis. A bare 
metal stent for younger patients (< 70 years).
− Bare metal stent or SVG for older patients (> 70 
years).
− Large right coronary artery, > 80% stenosis. 
Either a radial artery or an RGEA would be ap-
propriate in younger patients and an SVG would 
be reasonable in older patients.
Y grafts and their limitations
Left ITA/right ITA, and left ITA/RA composite Y 
grafts are excellent approaches to off-pump coronary 
surgery, so one can avoid proximal anastomoses to the 
aorta, particularly if it is atheromatous, and ensure ef-
ficient use of conduit17,25,29,38.
Excellent results and patencies can be achieved when 
the left ITA is confined to the LAD, and the RA to the 
circumflex branches. Extending the reach of the Y RA 
to the posterior descending artery may result in inferior 
patencies (Fig. 9). Hence, unless there was a conduit 
shortage, a separate graft to the posterior descending 
artery is recommended8,41. 
Proximal arterial graft anastomoses to 
the aorta
Some are concerned that this may be a technical 
problem. In general, the proximal end of the right ITA 
and RA are of excellent size (3-4 mm) with a robust 
wall. The construction of the proximal anastomoses is 
no different to that of a SVG to aorta proximal anasto-
mosis. In an experience of over 10,000 CABG, a vein 
patch-enhanced proximal anastomosis has only been re-
quired once. There is also concern that by constructing 
a free right ITA or an RA as an aorta to coronary con-
duit, it transposes these vessels from a third or fourth 
order branch to a first order branch, and the abrupt direct 
effects of arterial systolic pressure may induce a greater 
reactivity and medial proliferation and reduce patency. 
This has been shown not to be true. Radial artery paten-
cies are identical and excellent whether they be in com-
posite pedicled grafts, or aortocoronary grafts8,17,25,28-32. 
Possati, et al. found in 90 patients with angiogram a 
mean of 105 months post-op, RA patency rates of 91.6 
versus 97.5% for left ITA and 67% for SVG31. They 
also noted patent arterial grafts, including RA, were 
always smooth and free of any atheroma or intimal 
disease, even at 10 years post-op, unlike SVG. This has 
been reported by others8,17,25-31. Typical angiograms of 
arterial grafts, all more than 10 years post-op, are 
shown in figure 10.
RECOMMENDED GRAFT 
STRATEGIES
Patients less than 70 years old
Left ITA to LAD. Free or in situ right ITA to cir-
cumflex obtuse marginal, RA to posterior descending 
artery.
Patients more than 70 years old
Left ITA to LAD, RA to circumflex obtuse marginal, 
RA or SVG to posterior descending artery (we have 
Figure 8. Gastroepiploic artery brought anterior to the stomach through 
the diaphragm for anastomosis to the posterior descending artery can be 
performed on- or off-pump.
Gastro-
epiploic
artery
Posterior
descending
artery
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avoided in patients with Raynaud’s disease, sclero-
derma, or any other known collagen disease. Radial 
artery use should also be avoided if it is anticipated 
that there may be a requirement for high-dose vaso-
pressors.
ARTERIAL GRAFTS ARE SUPERIOR 
TO DRUG-ELUTING STENTS 
Arterial CABG produce equivalent short-term and 
superior mid-term (three years and beyond) outcomes 
with fewer major adverse cardiac events, fewer re-inter-
ventions, lower costs, and better survival34-36.
Importantly, two new complications associated with 
drug-eluting stents have become recognized.
First, the need for possible life-long clopidogrel. 
Acute thrombosis of the drug-eluting stent on withdraw-
al of clopidogrel occurs in 1-5% of cases and is associ-
ated with a 50% mortality42.
Second, coronary artery aneurysms associated with 
drug-eluting stents have also been recently reported, 
most likely due to the antimitotic effects of sirolimus 
and rapamycin, which inhibit smooth muscle cells and 
fibroblasts, resulting in a failure of vessel wall repair 
after balloon dilatation (Fig. 12). 
The increasing awareness of the limitations and prob-
lems associated with drug-eluting stents, and the greater 
awareness of informed patient consent afford a window 
of opportunity, in multi-vessel coronary disease, to es-
tablish the superiority of CABG, particularly by using 
multiple or total arterial grafting.
Figure 9. A string sign in the terminal part of the radial artery as it 
passes from the inferior marginal to the posterior descending artery. The 
radial artery (RA) inflow is from the left internal thoracic artery (LITA). 
The right coronary artery and posterior descending vessels in this ins-
tance only had a 50% stenosis, hence resulting in competitive flow, and 
a string sign, by comparison to the occluded circumflex system.
Figure 10. Angiograms of in situ right internal thoracic artery graft 
(RITA), free right internal thoracic artery graft (FRITA), used as a Y 
graft with a radial (RA) and radial artery grafts (RA). All angiograms 
are 10 or more years post-op. In all instances the patent grafts are smoo-
th and free of any atheromatous or luminal disease.
preferred RA, i.e. a second RA to posterior descending 
artery). However RGEA to posterior descending artery 
for either group (providing tight native coronary steno-
sis) is most reasonable.
Total arterial grafting is readily feasible in over 80% 
of CABG (Fig. 11).
PRACTICAL TIPS
Right internal thoracic artery
In situ right ITA will only readily reach the right 
coronary artery up to the acute margin (even skeleton-
ized). If one needs to go beyond this, particularly to 
beyond the crux, it is wiser to use the right ITA as a free 
graft.
The in situ right ITA, either anterior to the aorta or 
through the transverse sinus, will only readily reach the 
first circumflex marginal in most patients (even as a 
skeletonized graft). To go beyond this, the right ITA 
should be used as a free graft or as a Y graft from the 
left ITA.
The in situ right ITA should be passed behind the 
lobes of the thymus to protect from sternal infection or 
trauma.
The right internal thoracic vein should be divided, to 
prevent compression of the in situ right ITA.
Radial artery
An Allen’s test or one of its modifications should al-
ways be performed prior to RA use. The RA should be 
Arterial Gafts > 10 years
Post operativel
20
 123James Tatoulis: Injertos arteriales múltiples en cirugía coronaria: razonamiento e importancia
CONCLUSIONS
Coronary artery bypass grafting with multiple or to-
tal arterial grafting has a perioperative mortality and 
morbidity similar to or better than left ITA to LAD 
and SVG to others. The patencies of arterial grafts are 
superior at 10 years and beyond. There is less recur-
rent angina, cardiac events, myocardial infarctions, 
hospitalizations, and coronary re-interventions, and 
long-term survival is superior. Multiple arterial revas-
cularization is a powerful technique to compete with and 
trump angioplasty and stenting in patients with multi-
vessel coronary disease.
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